Timothy I. Musch

Timothy I. Musch

Auto-generated profile, based on publicly available information

Timothy I. Musch

Kansas State University

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2020 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
PDF file
DPDavid C. Poole
David C. Poole
SCSteven W. Copp
Steven W. Copp
TCTrenton D. Colburn
Trenton D. Colburn
JCJesse C. Craig
Jesse C. Craig
DADavid L. Allen
David L. Allen
TMTimothy I. Musch
Timothy I. Musch
Whole body exercise tolerance is the consummate example of integrative physiological function among the metabolic, neuromuscular, cardiovascular, and respiratory systems. Depending on the animal selected, the energetic demands and flux through the oxygen transport system can increase two orders of magnitude from rest to maximal exercise. Thus, animal models in health and disease present the scientist with flexible, powerful, and, in some instances, purpose-built tools to explore the mechanistic bases for physiological function and help unveil the causes for pathological or age-related exercise intolerance. Elegant experimental designs and analyses of kinetic parameters and steady-state responses permit acute and chronic exercise paradigms to identify therapeutic targets for drug development in disease and also present the opportunity to test the efficacy of pharmacological and behavioral countermeasures during aging, for example. However, for this promise to be fully realized, the correct or optimal animal model must be selected in conjunction with reproducible tests of physiological function (e.g., exercise capacity and maximal oxygen uptake) that can be compared equitably across laboratories, clinics, and other proving grounds. Rigorously controlled animal exercise and training studies constitute the foundation of translational research. This review presents the most commonly selected animal models with guidelines for their use and obtaining reproducible results and, crucially, translates state-of-the-art techniques and procedures developed on humans to those animal models.Listen to this article’s corresponding podcast at: https://ajpheart.podbean.com/e/guidelines-for-animal-exercise-and-training-protocols/ .

1 January 2018 in Journal of Applied Physiology
Verified
Journal Article
Closed access
PDF file
DPDavid C. Poole
David C. Poole
RRRussell S. Richardson
Russell S. Richardson
MHMark J. Haykowsky
Mark J. Haykowsky
DHDaniel M. Hirai
Daniel M. Hirai
TMTimothy I. Musch
Timothy I. Musch
The hallmark symptom of chronic heart failure (HF) is severe exercise intolerance. Impaired perfusive and diffusive O2 transport are two of the major determinants of reduced physical capacity and lowered maximal O2 uptake in patients with HF. It has now become evident that this syndrome manifests at least two different phenotypic variations: heart failure with preserved or reduced ejection fraction (HFpEF and HFrEF, respectively). Unlike HFrEF, however, there is currently limited understanding of HFpEF pathophysiology, leading to a lack of effective pharmacological treatments for this subpopulation. This brief review focuses on the disturbances within the O2 transport pathway resulting in limited exercise capacity in both HFpEF and HFrEF. Evidence from human and animal research reveals HF-induced impairments in both perfusive and diffusive O2 conductances identifying potential targets for clinical intervention. Specifically, utilization of different experimental approaches in humans (e.g., small vs. large muscle mass exercise) and animals (e.g., intravital microscopy and phosphorescence quenching) has provided important clues to elucidating these pathophysiological mechanisms. Adaptations within the skeletal muscle O2 delivery-utilization system following established and emerging therapies (e.g., exercise training and inorganic nitrate supplementation, respectively) are discussed. Resolution of the underlying mechanisms of skeletal muscle dysfunction and exercise intolerance is essential for the development and refinement of the most effective treatments for patients with HF.

1 May 2007 in Respiratory Physiology & Neurobiology
Verified
Journal Article
Closed access
DPDanielle J. Padilla
Danielle J. Padilla
PMPaul McDonough
Paul McDonough
BBBrad J. Behnke
Brad J. Behnke
YKYutaka Kano
Yutaka Kano
KHK. Sue Hageman
K. Sue Hageman
DPDavid Poole
David Poole

3 March 2020 in The Journal of Physiology
Verified
Journal Article
Open access
PDF file
DPDavid Poole
David Poole
BBBrad J. Behnke
Brad J. Behnke
TMTimothy I. Musch
Timothy I. Musch
Three sentinel parameters of aerobic performance are the maximal oxygen uptake (), critical power (CP) and speed of the kinetics following exercise onset. Of these, the latter is, perhaps, the cardinal test of integrated function along the O2 transport pathway from lungs to skeletal muscle mitochondria. Fast kinetics demands that the cardiovascular system distributes exercise‐induced blood flow elevations among and within those vascular beds subserving the contracting muscle(s). Ideally, this process must occur at least as rapidly as mitochondrial metabolism elevates . Chronic disease and ageing create an O2 delivery (i.e. blood flow × arterial [O2], ) dependency that slows kinetics, decreasing CP and , increasing the O2 deficit and sowing the seeds of exercise intolerance. Exercise training, in contrast, does the opposite. Within the context of these three parameters (see Graphical Abstract), this brief review examines the training‐induced plasticity of key elements in the O2 transport pathway. It asks how structural and functional vascular adaptations accelerate and redistribute muscle and thus defend microvascular O2 partial pressures and capillary blood–myocyte O2 diffusion across a ∼100‐fold range of muscle values. Recent discoveries, especially in the muscle microcirculation and ‐to‐ heterogeneity, are integrated with the O2 transport pathway to appreciate how local and systemic vascular control helps defend kinetics and determine CP and in health and how vascular dysfunction in disease predicates exercise intolerance. Finally, the latest evidence that nitrate supplementation improves vascular and therefore aerobic function in health and disease is presented. image

30 January 2018 in The Journal of Physiology
Verified
Journal Article
Closed access
PDF file
DHDaniel M. Hirai
Daniel M. Hirai
JCJesse C. Craig
Jesse C. Craig
TCTrenton D. Colburn
Trenton D. Colburn
HEHiroaki Eshima
Hiroaki Eshima
YKYutaka Kano
Yutaka Kano
DPDavid Poole
David Poole

12 September 2020 in The Journal of Physiology
Verified
Journal Article
Open access
PDF file
DPDavid Poole
David Poole
RPRoland N. Pittman
Roland N. Pittman
TMTimothy I. Musch
Timothy I. Musch
LØLeif Østergaard
Leif Østergaard
August Krogh twice won the prestigious international Steegen Prize, for nitrogen metabolism (1906) and overturning the concept of active transport of gases across the pulmonary epithelium (1910). Despite this, at the beginning of 1920, the consummate experimentalist was relatively unknown worldwide and even among his own University of Copenhagen faculty. But, in early 1919, he had submitted three papers to Dr Langley, then editor ofThe Journal of Physiologyin England. These papers coalesced anatomical observations of skeletal muscle capillary numbers with O2diffusion theory to propose a novel active role for capillaries that explained the prodigious increase in blood‐muscle O2flux from rest to exercise. Despite his own appraisal of the first two papers as “rather dull” to his friend, the eminent Cambridge respiratory physiologist, Joseph Barcroft, Krogh believed that the third one, dealing with O2supply and capillary regulation, was“interesting”. These papers, which won Krogh an unopposed Nobel Prize for Physiology or Medicine in 1920, form the foundation for this review. They single‐handedly transformed the role of capillaries from passive conduit and exchange vessels, functioning at the mercy of their upstream arterioles, into independent contractile units that were predominantly closed at rest and opened actively during muscle contractions in a process he termed ‘capillary recruitment’. Herein we examine Krogh's findings and some of the experimental difficulties he faced. In particular, the boundary conditions selected for his model (e.g. heavily anaesthetized animals, negligible intramyocyte O2partial pressure, binary open‐closed capillary function) have not withstood the test of time. Subsequently, we update the reader with intervening discoveries that underpin our current understanding of muscle microcirculatory control and place a retrospectroscope on Krogh's discoveries. The perspective is presented that the imprimatur of the Nobel Prize, in this instance, may have led scientists to discount compelling evidence. Much as he and Marie Krogh demonstrated that active transport of gases across the blood‐gas barrier was unnecessary in the lung, capillaries in skeletal muscle do not open and close spontaneously or actively, nor is this necessary to account for the increase in blood‐muscle O2flux during exercise. Thus, a contemporary model of capillary function features most muscle capillaries supporting blood flow at rest, and, rather than capillaries actively vasodilating from rest to exercise, increased blood‐myocyte O2flux occurs predominantly via elevating red blood cell and plasma flux in already flowing capillaries. Krogh is lauded for his brilliance as an experimentalist and for raising scientific questions that led to fertile avenues of investigation, including the study of microvascular function. image